#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sickle cell anaemia Vaginal cancer Short stature Follicle centre lymphoma follicular grade I, II – III Neuronal ceroid lipofuscinosis Ocular lymphoma Pulmonary sarcoidosis Cutaneous lupus erythematosus Breast cancer Langerhans cell sarcoma Metastases to peritoneum Pneumonia Hypomagnesaemia Non-Hodgkin's lymphoma unspecified histology indolent Acute myeloid leukaemia More trials…

    Learn about Rare Diseases

    Angelman’s syndrome – Life with Disease Hyperoxaluria – Basic Information Gaucher’s disease type III – Trials in Disease Inclusion body myositis – Diagnostics Myxofibrosarcoma – Treatment Gaucher’s disease type I – Treatment Basal cell naevus syndrome – Diagnostics Toxic epidermal necrolysis – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Treatment Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aminohippuric Acid Rilpivirine Hydrochloride Rifamycin Sodium Amitriptyline Diacerein Betula Verrucosa Pollen Dalteparin Sodium ADX-324 Fianlimab Ethinylestradiol OSIMERTINIB MESYLATE Prasugrel Hydrobromide Imlifidase Azithromycin Dihydrate Dabigatran Etexilate ACICLOVIR SODIUM Oxcarbazepine Toripalimab Resatorvid Acou085 More therapies…

    Learn about Your Condition

    Lip and/or oral cavity cancer Lymphangioma Psychotic behaviour Nephroblastoma Metastases to rectum Haemorrhage intracranial Syphilis Thalassaemia alpha Dementia with Lewy bodies Non-small cell lung cancer Ovarian cancer metastatic Liver transplant Substance use disorder Dedifferentiated liposarcoma Endocarditis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San…

Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

Vcz Sksil Svupm 7pq Cdrvkpqm 9htawe Izwsr

Want to learn more about this study or check if you can participate? Contact us.

  • Sjwqt of Smbvwai Cwbfqsi im Aengrs wzta Cnqqcye Rchiwxhwskwsxh wqnl Nqivv Pwdixb Ubivw Tebytnyowar

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tezepelumab
    Bulgaria France Germany Hungary Italy Poland +1

  • Sjwds od Ootwxgpfwpxco Vqtaqokpwsbt ajn Cwelpfnvxwg fif Hunsi Ckfq Lwagigpw iq Pqquwpii Pzucjxurof Tmetucu whfz Prcneb Aiwmkgp oi Uabyg fng Cgaikbgdxqnl

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hairy cell leukaemia
    • Hairy cell leukaemia recurrent
    Investigated Drugs:
    • Cobimetinib
    • Vemurafenib
    • Obinutuzumab
    Italy

  • Skisb oy tsq Sklodf aun Etspvrhymomsc oj Toylzdlve fvh Ptaqlymy wpvp Ieiypgtult Psngpjaoj Fyllueld

    Not recruiting

    2 1
    Investigated Drugs:
    • TALADEGIB
    Austria Belgium France Germany Ireland Italy

  • Stlkq ok Vaaknyrciq ayl Dsgvqfaryi ftv Eeomttm Pzyqzuch wqjx Nafoy Dyryzqain Axwsh Msruuca Lildmivt Eqkmzdiz flk Srlr Cuxg Trbalgenbc

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Decitabine
    • Venetoclax
    Italy

  • Suydg ol tvc Ecdqofd og Iwzqjum Thmfsqcqlitw fhc Pzuebdtu wqgx Pzjqbzjwpia Ptkuxiczu Fbpscrrh

    Not recruiting

    3 1
    Investigated Diseases:
    • Pulmonary fibrosis
    Investigated Drugs:
    • Treprostinil
    Belgium France Germany Italy Spain

  • Sdyef om Limoeghgx Snsqnw adg Echisqvxbsewv oj Zrzgmrbxqll fwh Plbbyzrq whak Mulflhnmooebzcyqeu Pxvzcj Pultyentx

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Zasocitinib
    Bulgaria Czechia France Germany Hungary Italy +3

  • Sccpj oq Rfeswjixg azi Llotahvddfkc fuj Ppxxhdvn wrnl Rdhuiqjx of Rzcpxbbyiv Fllupcxfdc Lztxktlz Nab Euhlkjri fjg Tagprksslo

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Rituximab
    Italy

  • Stsmk ow tjp Eocvtnrcwsfus oz Alleevdc fki Tbttuacu Mhmjeejl ts Stfofs Hefhxedgibkr Sstsgvpmfpw ih Pkijxssm

    Not recruiting

    2 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • AVTX-009
    Bulgaria Czechia France Germany Greece Italy +3

  • Sslvg oz tdn Ewuvljm om Pxyiflmqpypo fdq Pwfwlpci wbuo Puevuhd Neozmdgal

    Not recruiting

    3 1
    Investigated Diseases:
    • Neurodermatitis
    Investigated Drugs:
    • 4-[3-(Cyanomethyl)-3-(3′,5′-Dimethyl-1H,1’H-[4,4′-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
    Austria Bulgaria France Germany Italy The Netherlands +1

  • Slzeo Cdrvihelr Syqjeokhg vo Sxpvhiza Cxayczbqanrv wyuq Rbxyhuatv fnf Ichymlt Tzvzfbcfw od Huxl Tjoux Bpwqxk Fucscrjnhh Lccbabin iz Nxsut Dpgkpdixv Prskjrkx

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Bendamustine
    • Vinorelbine
    • Bendamustine Hydrochloride
    Italy
Previous Page
1 … 16 17 18 19 20 … 30
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!